Cardiology

The CGTLive Cardiology specialty topic page contains video interviews with key opinion leaders in the field of cardiology and up-to-date clinical news coverage on the latest cardiology gene and cell therapies for heart disease. It houses information on relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for heart conditions.

Latest News

Solid Biosciences’ Friedreich Ataxia Gene Therapy SGT-212 Garners Fast Track Designation
Solid Biosciences’ Friedreich Ataxia Gene Therapy SGT-212 Garners Fast Track Designation

January 21st 2025

SGT-212, a dual route gene transfer therapy, is intended to be delivered both by intradentate nucleus infusion and IV infusion at the same time.

Around the Helix: Cell and Gene Therapy Company Updates – January 15, 2025
Around the Helix: Cell and Gene Therapy Company Updates – January 15, 2025

January 15th 2025

Tenaya’s Hypertrophic Cardiomyopathy Gene Therapy TN-201 Well-Tolerated in Early Clinical Data
Tenaya’s Hypertrophic Cardiomyopathy Gene Therapy TN-201 Well-Tolerated in Early Clinical Data

January 9th 2025

Around the Helix: Cell and Gene Therapy Company Updates – January 8, 2025
Around the Helix: Cell and Gene Therapy Company Updates – January 8, 2025

January 8th 2025

CGTLive's 2024 Pillars of Progress: Top News in Cardiology
CGTLive's 2024 Pillars of Progress: Top News in Cardiology

December 30th 2024

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.